Feedback / Questions
Gazyva (obinutuzumab) - Roche, Biogen
Gazyva: Regulatory submission in Japan for lupus nephritis in 2026
(Chugai)
-
Oct 27, 2026 -
Q3 FY2026 Results: Regulatory submission in Japan for extra renal lupus in 2027
Japan filing
•
Immunology • Lupus • Lupus Nephritis
https://www.chugai-pharm.co.jp/cont_file_dl.php?f=FILE_5_77.pdf&src=[%0],[%1]&rep=137,77
Oct 27, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next